TY  - GEN 
AU  - Mareque, María
AU  - Mingot-Castellano, María Eva
AU  - López Fernández, María Fernanda
AU  - Álvarez-Román, María Teresa
AU  - Oyagüez, Itziar
PY  - 2020
SN  - 0902-4441
UR  - http://hdl.handle.net/20.500.11940/16225
AB  - OBJECTIVES: This study estimated the cost of prophylaxis with activated prothrombin complex concentrate (aPCC) and recombinant activated factor VIIa (rFVIIa) in surgical patients with haemophilia A and inhibitors in Spain. METHODS: A decision-analytic...
KW  - Hemophilia A
KW  - Humans
KW  - Factor VIIa
KW  - Recombinant Proteins
KW  - Blood Coagulation Factor Inhibitors
KW  - Isoantibodies
KW  - Hemorrhage
KW  - Health Care Surveys
TI  - Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain
DO  - 10.1111/ejh.13414
KW  - CHUAC
VL  - 105
ER  -